Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.39% is 66% below its 5-year average of 1.13%, near the low end of its 5-year range (0.00%–1873.76%).
As of the fiscal period ended Tuesday, June 30, 2026. 62.58% below its 12-month average of 1.03%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.39%.
DEBT TO ASSETS RATIO
0.39%
DEBT TO ASSETS RATIO AVG TTM
1.03%
DEBT TO ASSETS RATIO AVG 3Y
1.50%
DEBT TO ASSETS RATIO AVG 5Y
1.13%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-62.58%
CURRENT VS 3Y AVG
-74.18%
CURRENT VS 5Y AVG
-65.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 808 covered companies
CURRENT VS SECTOR MEDIAN
+329.60%
vs the sector median at left
Market Cap
$4.08M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.07M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.00M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.34M
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.82M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.52M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRI Bio, Inc. (GRI) | $4.15M | 0.39% | 1.03% | 1.50% | 1.13% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $4.08M | 0.04% | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.23M | 0.09% | N/A | N/A | N/A |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.07M | 0.00% | N/A | N/A | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.00M | 0.29% | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | 0.37% | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.82M | 0.06% | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.79M | 0.16% | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.52M | 0.00% | N/A | N/A | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.64M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.4%
Debt/Equity
0.00
Current Ratio
10.30
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.39% |
| 2026-04-30 | 0.51% |
| 2026-01-31 | 0.82% |
| 2025-10-31 | 1.76% |
| 2025-07-31 | 1.69% |
| 2025-04-30 | 2.67% |
| 2025-01-31 | 2.07% |
| 2024-10-31 | 2.40% |
| 2024-07-31 | 2.01% |
| 2024-04-30 | 3.31% |
| 2024-01-31 | 0.47% |
| 2023-09-30 | 0.64% |
| 2023-06-30 | 0.73% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 175.72% |
| 2022-09-30 | 1873.76% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 2.03% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 1.65% |
| 2020-12-31 | 35.18% |
| 2020-09-30 | 21.34% |
| 2020-06-30 | 14.54% |
| 2019-12-31 | 7.95% |
